BidaskClub cut shares of Teleflex Incorporated (NYSE:TFX) from a hold rating to a sell rating in a report released on Tuesday.

A number of other equities analysts have also commented on the stock. Zacks Investment Research upgraded shares of Teleflex from a hold rating to a buy rating and set a $228.00 price target on the stock in a research report on Friday, June 23rd. Barclays PLC restated a buy rating on shares of Teleflex in a research report on Monday, June 26th. Deutsche Bank AG boosted their price target on shares of Teleflex from $213.00 to $220.00 and gave the company a buy rating in a research report on Monday, May 8th. Needham & Company LLC restated a buy rating and issued a $224.00 price target on shares of Teleflex in a research report on Friday, May 5th. Finally, Leerink Swann boosted their target price on shares of Teleflex from $215.00 to $220.00 and gave the stock a market perform rating in a research note on Friday, June 9th. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. Teleflex currently has a consensus rating of Buy and an average price target of $228.00.

Teleflex (NYSE:TFX) traded up 0.83% during midday trading on Tuesday, reaching $205.36. 92,714 shares of the company traded hands. The firm has a market capitalization of $9.25 billion, a price-to-earnings ratio of 39.27 and a beta of 1.05. Teleflex has a 12 month low of $136.53 and a 12 month high of $217.97. The firm’s 50 day moving average price is $209.38 and its 200 day moving average price is $196.62.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, beating the Zacks’ consensus estimate of $1.91 by $0.13. The firm had revenue of $528.60 million for the quarter, compared to analyst estimates of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.89 earnings per share. On average, analysts expect that Teleflex will post $8.28 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/08/11/teleflex-incorporated-tfx-lowered-to-sell-at-bidaskclub.html.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is 26.00%.

In related news, Director Stephen K. M.D. Klasko sold 5,200 shares of the business’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $193.56, for a total transaction of $1,006,512.00. Following the completion of the sale, the director now directly owns 12,880 shares of the company’s stock, valued at $2,493,052.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Stuart A. Randle sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $205.67, for a total transaction of $514,175.00. Following the sale, the director now directly owns 7,532 shares of the company’s stock, valued at $1,549,106.44. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,300 shares of company stock valued at $1,643,975. 2.39% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the company. Asset Planning Services Ltd. purchased a new stake in shares of Teleflex during the first quarter valued at approximately $116,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in shares of Teleflex during the first quarter valued at approximately $155,000. OLD Mutual Customised Solutions Proprietary Ltd. increased its stake in shares of Teleflex by 200.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock valued at $174,000 after buying an additional 600 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Teleflex during the second quarter valued at approximately $200,000. Finally, Calamos Advisors LLC purchased a new stake in shares of Teleflex during the second quarter valued at approximately $206,000. 93.02% of the stock is owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.